30 Day Trial

DePuy Synthes 2Q17 Orthopaedic Revenue

Share:

ORTHOWORLD estimates DePuy Synthes’ 2Q17 orthopaedic revenue at US $2,214.8MM, +0.4% vs. 2Q16.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.